Evidence map›Paper›PMID 42432761›Full record

ArticleJournal of biological engineering2026

A strategy of 3D-printed Ta4C3 MXenes nanohydroxyapatite/methacryloylated silk fibroin scaffolds for postsurgical management of osteosarcoma.

Liu Yang, Kenan Sun, Shihao Deng, Shuai Liang, Shaoze Lan, Canming Ye, Ciren Lunzhu, Runguang Li, Runhuai Yang, Jun Li

Abstract read
In one paragraph

Article in Journal of biological engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Liu Yang *Department of Orthopedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Kenan Sun *Department of Orthopedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Shihao Deng *Department of burn and injury, The Second Affiliated Hospital of Kunming Medical University, Kunming, 650101, China.
Shuai LiangDepartment of Orthopedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.ORCID http://orcid.org/0000-0002-1397-0001
Shaoze LanDepartment of Orthopedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Canming YeDepartment of Orthopedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
Ciren LunzhuDepartment of Orthopedics, Shannan City People's Hospital, Shannan, Xizang, 856004, China.
Runguang Li *Center for Orthopaedic Surgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510610, China. lirunguang79@163.com.
Runhuai Yang *School of Biomedical Engineering, Anhui Provincial Institute of Translational Medicine, Anhui Medical University, No. 678 Furong Road, Economic Development Zone, Hefei, 230032, P. R. China. yangrunhuai@ahmu.edu.cn.
Jun Li *Department of Orthopedics, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China. efylijunpaper@163.com.ORCID http://orcid.org/0000-0001-6383-6065

Funding

Basic and Clinical Cooperative Research Promotion Plan of Anhui Medical University No. 2020xkjT040Clinical Research cultivation Program of the Second Affiliated Hospital of Anhui Medical University No. 2020LCZD20National Natural Science Foundation Incubation Program of the Second Affiliated Hospital of Anhui Medical University No. 2024GMFY01Provincial Quality Engineering Program for Higher Education Institutions in Anhui Province No. 2022sx075 and No. 2022jyxm739Research Fund of Anhui Institute of translational medicine No. 2022zhyx-C44Technology Plan Project of Shannan City No. SNSBJKJJHXM2023015The New Era Education Quality Project of Anhui Provincial Department of Education 2023zyxwjxalk054Tibet Autonomous Region Natural Science Foundation Grouped Assistance to Tibet Medical Project No. XZ2023ZR-ZY47(Z)
6 · The paper itself

Abstract

The postoperative repair of bone tumors remains a significant clinical challenge requiring urgent solutions, and this holds particularly true for regenerating large bone defects, completely removing residual tumor cells, and effectively preventing and controlling postoperative infections. The efficacy of traditional single treatments is limited, as they generally target only one of these challenges. To overcome this dilemma, this study designed a multifunctional composite nanoscaffold by applying Ta4C3 MXenes nanosheets to the surface of a 3D printed nano-hydroxyapatite (nHA)/methacrylated silk fibroin (MASF) composite scaffold through in situ anchoring. 3D printing technology fabricated a porous hierarchical architecture matching the target bone defect, which provides a suitable three-dimensional microenvironment for bone cell adhesion, proliferation, and differentiation. The main inorganic component of natural bone, nHA, was included to promote bone tissue mineralization. Additionally, with good biocompatibility and degradability, MASF acts as the organic matrix and facilitates the stable loading of the Ta4C3 MXenes nanosheets. To be more specific, the introduction of Ta4C3 MXenes nanosheets endows the scaffold with excellent photothermal conversion capabilities, enabling the generation of precise and controllable local high temperatures upon near-infrared light irradiation. This property allows it to efficiently kill residual tumor cells through thermal ablation while also exhibiting excellent broad-spectrum antibacterial activity through its thermal effects. This implantable material integrates bone defect repair, tumor clearance, and anti-infection functions, thereby effectively solving the limitations of traditional single therapies. It also provides new ideas for the clinical treatment of tumor-related bone defects and exhibits great application prospects.

Indexed as

3D printingBone defectMethacryloylated silk fibroinMXenesNanohydroxyapatiteOsteosarcoma

Identifiers

PMID42432761
PMCPMC13637287

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.